Press Resease

Liquid Biopsy Market - Global Industry Analysis

Liquid Biopsy Market by Target Analyte (Circulating Tumor Cells (Ctcs), Circulating Tumor DNA (CtDNA), Exosomes, Nucleosomes, and Other Biomarkers), by Analytical (Molecular, Proteomic, and Histology/Imaging), by Application (Routine Screening, Patient Work-Up, Early-Stage Disease, and Late-Stage/Metastatic Disease), by Cancer Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Brain Cancer, and Others), by Sample (Blood, Urine, and Others), and by End-User (Hospitals, Research Laboratories, Academia, and Research Centers): Global Industry Perspective Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 09-May-2019 Category: Pharmaceutical Report Format : PDF Pages: 130 Report Code: ZMR-884 Status : Published

Global liquid biopsy market expected to generate approximately USD 12,062 million by 2025, at a CAGR of slightly above 38.3% between 2019 and 2025. A biopsy is a tissue or cell sample taken from any part of the human body, which is sent to the lab for examining various disease types.

Description

The report covers a forecast and an analysis of the liquid biopsy market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the liquid biopsy market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the liquid biopsy market on a global level.

In order to give the users of this report a comprehensive view of the liquid biopsy market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Liquid Biopsy Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product, and regional expansion of major participants involved in the market.

The study provides a decisive view of the liquid biopsy market based on target analyte, analytical, application, sample, cancer type, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players in the global liquid biopsy market include Biocept, Cynvenio, NeoGenomics Laboratories, Qiagen, Trovagene, RainDance Technologies, Guardant Health, Exosome Diagnostics, SAGA Diagnostics AB, Circulogene Theranostics, Inivata, Agena Bioscience, Admeria Health Personal Genome Diagnostics, and Adaptive Biotechnologies.

This report segments the global liquid biopsy market into:

Global Liquid Biopsy Market: Target Analyte Analysis

  • Circulating Tumor Cells
  • Circulating Tumor DNA
  • Exosomes
  • Nucleosomes
  • Other Biomarkers

Global Liquid Biopsy Market: Analytical Analysis

  • Molecular
  • Proteomic
  • Histology/Imaging

Global Liquid Biopsy Market: Application Analysis

  • Routine Screening
  • Patient Work Up
  • Early-Stage Disease
  • Late Stage/Metastatic Disease

Global Liquid Biopsy Market: Sample Analysis

  • Blood
  • Urine
  • Others

Global Liquid Biopsy Market: Cancer Type Analysis

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Brain Cancer
  • Prostate Cancer
  • Others

Global Liquid Biopsy Market: End-User Analysis

  • Hospitals
  • Research Laboratories
  • Academia
  • Research Centers

Global Liquid Biopsy Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Liquid Biopsy Market, 2016-2025 (USD Million)
    • 2.2. Liquid Biopsy Market: Market Snapshot
  •  
  • Chapter 3. Liquid Biopsy Market - Industry Analysis
    • 3.1. Liquid Biopsy Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rising incidences of cancer
      • 3.2.2. Growing demand for minimally invasive surgeries
      • 3.2.3. Escalating demand for personalized medicine
      • 3.2.4. Rising healthcare expenditure
    • 3.3. Restraints
      • 3.3.1. Stringent regulatory policies
      • 3.3.2. Lack of clarity in medical pricing
      • 3.3.3. Unclear reimbursement policies
      • 3.3.4. Alternatives to liquid biopsies
    • 3.4. Opportunity
      • 3.4.1. Expanding in-vitro diagnostic market
      • 3.4.2. Emerging economies like India and China
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by target analyte
      • 3.6.2. Market attractiveness analysis by analytical
      • 3.6.3. Market attractiveness analysis by cancer type
      • 3.6.4. Market attractiveness analysis by application
      • 3.6.5. Market attractiveness analysis by sample
      • 3.6.6. Market attractiveness analysis by end-user
      • 3.6.7. Market attractiveness analysis by region
  •  
  • Chapter 4. Liquid Biopsy Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global liquid biopsy market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
    • 4.3. Price trend analysis
  •  
  • Chapter 5. Global Liquid Biopsy Market - Target Analyte Analysis
    • 5.1. Global liquid biopsy market overview: by target analyte
      • 5.1.1. Global liquid biopsy market revenue share, by target analyte, 2018 and 2025
    • 5.2. Circulating Tumor Cells
      • 5.2.1. Global liquid biopsy market by circulating tumor cells, 2016-2025 (USD Million)
    • 5.3. Circulating Tumor DNA
      • 5.3.1. Global liquid biopsy market by circulating tumor DNA, 2016-2025 (USD Million)
    • 5.4. Exosomes
      • 5.4.1. Global liquid biopsy market by exosomes, 2016-2025 (USD Million)
    • 5.5. Nucleosomes
      • 5.5.1. Global liquid biopsy market by nucleosomes, 2016-2025 (USD Million)
    • 5.6. Biomarkers
      • 5.6.1. Global liquid biopsy market by other biomarkers, 2016-2025 (USD Million)
  •  
  • Chapter 6. Global Liquid Biopsy Market - Analytical Analysis
    • 6.1. Global liquid biopsy market overview: by analytical
      • 6.1.1. Global liquid biopsy market revenue share, by analytical, 2018 and 2025
    • 6.2. Molecular
      • 6.2.1. Global liquid biopsy market by molecular, 2016-2025 (USD Million)
    • 6.3. Proteomic
      • 6.3.1. Global liquid biopsy market by proteomic, 2016-2025 (USD Million)
    • 6.4. Histology/ Imaging
      • 6.4.1. Global liquid biopsy market by histology/imaging, 2016-2025 (USD Million)
  •  
  • Chapter 7. Global Liquid Biopsy Market - Application Analysis
    • 7.1. Global liquid biopsy market overview: by application
      • 7.1.1. Global liquid biopsy market revenue share, by application, 2018 and 2025
    • 7.2. Routine Screening
      • 7.2.1. Global liquid biopsy market for routine screening, 2016-2025 (USD Million)
    • 7.3. Patient Work-Up
      • 7.3.1. Global liquid biopsy market for patient work-up, 2016-2025 (USD Million)
    • 7.4. Early Stage Disease
      • 7.4.1. Global liquid biopsy market for early-stage disease, 2016-2025 (USD Million)
    • 7.5. Late Stage/ Metastatic Disease
      • 7.5.1. Global liquid biopsy market for late stage/metastatic disease, 2016-2025 (USD Million)
  •  
  • Chapter 8. Global Liquid Biopsy Market - Cancer Type Analysis
    • 8.1. Global liquid biopsy market overview: by cancer type
      • 8.1.1. Global liquid biopsy market revenue share, by cancer type, 2018 and 2025
    • 8.2. Breast Cancer
      • 8.2.1. Global liquid biopsy market for breast cancer, 2016-2025 (USD Million)
    • 8.3. Prostate Cancer
      • 8.3.1. Global liquid biopsy market for prostate cancer, 2016-2025 (USD Million)
    • 8.4. Colorectal Cancer
      • 8.4.1. Global liquid biopsy market for colorectal cancer, 2016-2025 (USD Million)
    • 8.5. Brain Cancer
      • 8.5.1. Global liquid biopsy market for brain cancer, 2016-2025 (USD Million)
    • 8.6. Lung Cancer
      • 8.6.1. Global liquid biopsy market for lung cancer, 2016-2025 (USD Million)
    • 8.7. Other
      • 8.7.1. Global liquid biopsy market for others, 2016-2025 (USD Million)
  •  
  • Chapter 9. Global Liquid Biopsy Market - Sample Analysis
    • 9.1. Global liquid biopsy market overview: by sample
      • 9.1.1. Global liquid biopsy market revenue share, by sample, 2018 and 2025
    • 9.2. Blood
      • 9.2.1. Global liquid biopsy market for blood, 2016-2025 (USD Million)
    • 9.3. Urine
      • 9.3.1. Global liquid biopsy market for urine, 2016-2025 (USD Million)
    • 9.4. Others
      • 9.4.1. Global liquid biopsy market for others, 2016-2025 (USD Million)
  •  
  • Chapter 10. Global Liquid Biopsy Market - End-User Analysis
    • 10.1. Global liquid biopsy market overview: by end-user
      • 10.1.2. Global liquid biopsy market revenue share, by end-user, 2018 and 2025
    • 10.2. Hospitals
      • 10.2.1. Global liquid biopsy market for hospitals, 2016-2025 (USD Million)
    • 10.3. Research Laboratories
      • 10.3.1. Global liquid biopsy market for research laboratories, 2016-2025 (USD Million)
    • 10.4. Academia
      • 10.4.1. Global liquid biopsy market for academia, 2016-2025 (USD Million)
    • 10.5. Research Centers
      • 10.5.1. Global liquid biopsy market for research centers, 2016-2025 (USD Million)
  •  
  • Chapter 11. Global Liquid Biopsy Market - Regional Analysis
    • 11.1. Global liquid biopsy market overview: by region
      • 11.1.1. Global liquid biopsy market revenue share, by region, 2018 and 2025
    • 11.2. North America
      • 11.2.1. North America liquid biopsy market, 2016-2025 (USD Million)
      • 11.2.2. North America liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
      • 11.2.3. North America liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
      • 11.2.4. North America liquid biopsy market revenue, by application, 2016-2025 (USD Million)
      • 11.2.5. North America liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
      • 11.2.6. North America liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
      • 11.2.7. North America liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.2.8. The U.S.
        • 11.2.8.1. The U.S. Liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.2.8.2. The U.S. Liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.2.8.3. The U.S. Liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.2.8.4. The U.S. Liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.2.8.5. The U.S. Liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.2.8.6. The U.S. Liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.2.9. Canada
        • 11.2.9.1. Canada liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.2.9.2. Canada liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.2.9.3. Canada liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.2.9.4. Canada liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.2.9.5. Canada liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.2.9.6. Canada liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
    • 11.3. Europe
      • 11.3.1. Europe liquid biopsy market, 2016-2025 (USD Million)
      • 11.3.2. Europe liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
      • 11.3.3. Europe liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
      • 11.3.4. Europe liquid biopsy market revenue, by application, 2016-2025 (USD Million)
      • 11.3.5. Europe liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
      • 11.3.6. Europe liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
      • 11.3.7. Europe liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.3.8. U.K.
        • 11.3.8.1. U.K. liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.3.8.2. U.K. liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.3.8.3. U.K. liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.3.8.4. U.K. liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.3.8.5. U.K. liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.3.8.6. U.K. liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.3.9. France
        • 11.3.9.1. France liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.3.9.2. France liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.3.9.3. France liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.3.9.4. France liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.3.9.5. France liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.3.9.6. France liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.3.10. Germany
        • 11.3.10.1. Germany liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.3.10.2. Germany liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.3.10.3. Germany liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.3.10.4. Germany liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.3.10.5. Germany liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.3.10.6. Germany liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.3.11. Rest of Europe
        • 11.3.11.1. Rest of Europe liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.3.11.2. Rest of Europe liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.3.11.3. Rest of Europe liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.3.11.4. Rest of Europe liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.3.11.5. Rest of Europe liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.3.11.6. Rest of Europe liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
    • 11.4. Asia Pacific
      • 11.4.1. Asia Pacific liquid biopsy market, 2016-2025 (USD Million)
      • 11.4.2. Asia Pacific liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
      • 11.4.3. Asia Pacific liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
      • 11.4.4. Asia Pacific liquid biopsy market revenue, by application, 2016-2025 (USD Million)
      • 11.4.5. Asia Pacific liquid biopsy market revenue, by cancertype, 2016-2025 (USD Million)
      • 11.4.6. Asia Pacific liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
      • 11.4.7. Asia Pacific liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.4.8. China
        • 11.4.8.1. China liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.4.8.2. China liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.4.8.3. China liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.4.8.4. China liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.4.8.5. China liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.4.8.6. China liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.4.9. Japan
        • 11.4.9.1. Japan liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.4.9.2. Japan liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.4.9.3. Japan liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.4.9.4. Japan liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.4.9.5. Japan liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.4.9.6. Japan liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.4.10. India
        • 11.4.10.1. India liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.4.10.2. India liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.4.10.3. India liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.4.10.4. India liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.4.10.5. India liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.4.10.6. India liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.4.11. Rest of Asia Pacific
        • 11.4.11.1. Rest of Asia Pacific liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.4.11.2. Rest of Asia Pacific liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.4.11.3. Rest of Asia Pacific liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.4.11.4. Rest of Asia Pacific liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.4.11.5. Rest of Asia Pacific liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.4.11.6. Rest of Asia Pacific liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
    • 11.5. Latin America
      • 11.5.1. Latin America liquid biopsy market, 2016-2025 (USD Million)
      • 11.5.2. Latin America liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
      • 11.5.3. Latin America liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
      • 11.5.4. Latin America liquid biopsy market revenue, by application, 2016-2025 (USD Million)
      • 11.5.5. Latin America liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
      • 11.5.6. Latin America liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
      • 11.5.7. Latin America liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.5.8. Brazil
        • 11.5.8.1. Brazil liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.5.8.2. Brazil liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.5.8.3. Brazil liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.5.8.4. Brazil liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.5.8.5. Brazil liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.5.8.6. Brazil liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
      • 11.5.9. Rest of Latin America
        • 11.5.9.1. Rest of Latin America liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
        • 11.5.9.2. Rest of Latin America liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
        • 11.5.9.3. Rest of Latin America liquid biopsy market revenue, by application, 2016-2025 (USD Million)
        • 11.5.9.4. Rest of Latin America liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
        • 11.5.9.5. Rest of Latin America liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
        • 11.5.9.6. Rest of Latin America liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
    • 11.6. The Middle East and Africa
      • 11.6.1. The Middle East and Africa liquid biopsy market, 2016-2025 (USD Million)
      • 11.6.2. The Middle East and Africa liquid biopsy market revenue, by target analyte, 2016-2025 (USD Million)
      • 11.6.3. The Middle East and Africa liquid biopsy market revenue, by analytical, 2016-2025 (USD Million)
      • 11.6.4. The Middle East and Africa liquid biopsy market revenue, by application, 2016-2025 (USD Million)
      • 11.6.5. The Middle East and Africa liquid biopsy market revenue, by cancer type, 2016-2025 (USD Million)
      • 11.6.6. The Middle East and Africa liquid biopsy market revenue, by sample, 2016-2025 (USD Million)
      • 11.6.7. The Middle East and Africa liquid biopsy market revenue, by end-user, 2016-2025 (USD Million)
  •  
  • Chapter 12. Company Profiles
    • 12.1. Personal Genome Diagnostics
      • 12.1.1. Overview
      • 12.1.2. Financials
      • 12.1.3. Product Portfolio
      • 12.1.4. Business Strategy
      • 12.1.5. Recent Developments
    • 12.2. Biocept
      • 12.2.1. Overview
      • 12.2.2. Financials
      • 12.2.3. Product Portfolio
      • 12.2.4. Business Strategy
      • 12.2.5. Recent Developments
    • 12.3. Adaptive Biotechnologies
      • 12.3.1. Overview
      • 12.3.2. Financials
      • 12.3.3. Product Portfolio
      • 12.3.4. Business Strategy
      • 12.3.5. Recent Developments
    • 12.4. Cynvenio
      • 12.4.1. Overview
      • 12.4.2. Financials
      • 12.4.3. Product Portfolio
      • 12.4.4. Business Strategy
      • 12.4.5. Recent Developments
    • 12.5. NeoGenomics Laboratories
      • 12.5.1. Overview
      • 12.5.2. Financials
      • 12.5.3. Product Portfolio
      • 12.5.4. Business Strategy
      • 12.5.5. Recent Development
    • 12.6. Qiagen
      • 12.6.1. Overview
      • 12.6.2. Financials
      • 12.6.3. Product Portfolio
      • 12.6.4. Business Strategy
      • 12.6.5. Recent Developments
    • 12.7. Trovagene
      • 12.7.1. Overview
      • 12.7.2. Financials
      • 12.7.3. Product Portfolio
      • 12.7.4. Business Strategy
      • 12.7.5. Recent Developments
    • 12.8. RainDance Technologies
      • 12.8.1. Overview
      • 12.8.2. Financials
      • 12.8.3. Product Portfolio
      • 12.8.4. Business Strategy
      • 12.8.5. Recent Developments
    • 12.9. Guardant Health
      • 12.9.1. Overview
      • 12.9.2. Financials
      • 12.9.3. Product Portfolio
      • 12.9.4. Business Strategy
      • 12.9.5. Recent Developments
    • 12.10. Exosome Diagnostics
      • 12.10.1. Overview
      • 12.10.2. Financials
      • 12.10.3. Product Portfolio
      • 12.10.4. Business Strategy
      • 12.10.5. Recent Developments
    • 12.11. Exosome Diagnostics
      • 12.11.1. Overview
      • 12.11.2. Financials
      • 12.11.3. Product Portfolio
      • 12.11.4. Business Strategy
      • 12.11.5. Recent Developments
    • 12.12. Circulogene Theranostics
      • 12.12.1. Overview
      • 12.12.2. Financials
      • 12.12.3. Product Portfolio
      • 12.12.4. Business Strategy
      • 12.12.5. Recent Developments
    • 12.13. Inivata
      • 12.13.1. Overview
      • 12.13.2. Financials
      • 12.13.3. Product Portfolio
      • 12.13.4. Business Strategy
      • 12.13.5. Recent Developments
    • 12.14. Agena Bioscience
      • 12.14.1. Overview
      • 12.14.2. Financials
      • 12.14.3. Product Portfolio
      • 12.14.4. Business Strategy
      • 12.14.5. Recent Developments
    • 12.15. Exosome Diagnostics
      • 12.15.1. Overview
      • 12.15.2. Financials
      • 12.15.3. Product Portfolio
      • 12.15.4. Business Strategy
      • 12.15.5. Recent Developments
    • 12.16. Admeria Health
      • 12.16.1. Overview
      • 12.16.2. Financials
      • 12.16.3. Product Portfolio
      • 12.16.4. Business Strategy
      • 12.16.5. Recent Developments

Methodology

Free Analysis

A biopsy is a tissue or cell sample taken from any part of the human body, which is sent to the lab for examining various disease types. A liquid biopsy is an advanced form of treatment procedure for cancer, wherein bodily fluids like blood or urine are collected for disease detection. National Cancer Institute (NCI) defines liquid biopsy as a test performed on a blood sample to identify cancer cells from a tumor circulating in blood or DNA via tumor cells in the blood. A liquid biopsy helps in planning treatment regime along with finding out effective treatment options for the patients. Through liquid biopsy, specialist physicians are able to track different molecular changes occurring within tumor cells and put forth appropriate treatment procedures.

The global liquid biopsy market growth can be attributed to the increasing incidences of cancer, growing demand for minimally invasive surgeries and personalized medicine, and rising healthcare expenditure. Stringent regulatory policies, lack of clarity in medical pricing, unclear reimbursement policies, and the presence of alternatives to liquid biopsies may restraint the liquid biopsy market growth over the forecast time period.

Global Liquid Biopsy Market

The global liquid biopsy market is fragmented on the basis of target analyte, analytical, cancer type, sample, and end-user. The target analyte segment includes circulating tumor cells, circulating tumor DNA, exosomes, nucleosomes, and other biomarkers. The analytical segment includes molecular, proteomic, and histology/imaging. By cancer type, the market includes breast cancer, lung cancer, prostate cancer, colorectal cancer, brain cancer, and others. The sample segment includes urine, blood, and others. The end-user segment includes hospital, research laboratories, academia, and research centers.

The liquid biopsy market in the Asia Pacific region is estimated to show the highest CAGR over the forecast time period, owing to the rising cancer incidences, growing aging population, increasing privatization and deregulation within the healthcare sector, and provisional financing of health services across the region. Japan, Singapore, Australia, and the Republic of Korea remain key regional investors for liquid biopsy. Additionally, the global market will witness significant demand from developing economies like India and China. North America and Europe are considered to be the foremost regions for liquid biopsy market in terms of revenue, due to the increasing R&D expenditure, clarity in the regulatory process, growing demand for minimally invasive surgeries, and high expenditure related to healthcare.

Some major players in the global liquid biopsy market include Biocept, Cynvenio, NeoGenomics Laboratories, Qiagen, Trovagene, RainDance Technologies, Guardant Health, Exosome Diagnostics, SAGA Diagnostics AB, Circulogene Theranostics, Inivata, Agena Bioscience, Admeria Health Personal Genome Diagnostics, and Adaptive Biotechnologies.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social